Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

OBJECTIVE: The advent of immune checkpoint inhibitors (ICIs) has rapidly transformed the treatment paradigm of non-small cell lung cancer (NSCLC). Despite the durability of response to ICIs, the vast majority of patients will later develop progression. However, the failure patterns of ICI treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Rong, Yin, Yipengchen, Cai, Xuwei, Fu, Xiaolong, Zhang, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454403/
https://www.ncbi.nlm.nih.gov/pubmed/34557412
http://dx.doi.org/10.3389/fonc.2021.724722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454403/
https://www.ncbi.nlm.nih.gov/pubmed/34557412
http://dx.doi.org/10.3389/fonc.2021.724722

Ejemplares similares